Loading organizations...
Loading organizations...
High-tech design company accelerating bio-medicine development.
Hangzhou Just Biotherapeutics (Just China) has raised $35.0M across 1 funding round.
Hangzhou Just Biotherapeutics (Just China) has raised $35.0M in total across 1 funding round.
Hangzhou Just Biotherapeutics (Just China) has raised $35.0M in total across 1 funding round.
Hangzhou Just Biotherapeutics (Just China)'s investors include Hillhouse Capital, ARCH Venture Partners, Lilly Asia Ventures, Taikang, Temasek.
Hangzhou Just Biotherapeutics (Just China) has raised $35.0M across 1 funding round. Most recently, it raised $35.0M Series B in June 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 6, 2018 | $35.0M Series B | Hillhouse Capital | ARCH Venture Partners, Lilly Asia Ventures, Taikang, Temasek |